Premium
Real‐world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis
Author(s) -
Iznardo H.,
Vilarrasa E.,
LópezFerrer A.,
Puig L.
Publication year - 2021
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.20416
Subject(s) - medicine , ixekizumab , secukinumab , clinical trial , tolerability , plaque psoriasis , psoriasis , dermatology , family medicine , adverse effect , psoriatic arthritis